What:  Luncheon with the Experts presented by the Carcinoid Cancer Foundation

Who:
C. Christofer Juhlin, MD, PhD, is the featured guest

When: Thursday, May 5, 2022 from 12 noon to 1 pm, Eastern Time
Click on the orange date above to add the event to your calendar.
Where:  CCF’s Facebook Page, https://www.facebook.com/Carcinoid/. Just come to the page at noon and the program will begin. There is no need to register nor is there a special link.
For anyone not on Facebook, each of the presentations in the series is available on CCF’s YouTube channel, https://www.youtube.com/user/CarcinoidNETs. To receive notifications of all new videos on our YouTube channel, CLICK LIKE, SUBSCRIBE and HIT THE BELL to receive notifications each time a new video is uploaded.
C. Christofer Juhlin MD, PhD, is a pathologist and Associate Professor of Experimental Pathology at Karolinska Institutet in Sweden. He is also a Senior Consultant in Surgical Pathology at Karolinska University Hospital in Stockholm, with a special focus on endocrine pathology.
Dr. Juhlin’s research team focuses on delivering improved diagnostic and prognostic tools for tumors derived from endocrine tissues such as the thyroid and parathyroid glands in the neck as well as for abdominal neoplasias such as adrenal and neuroendocrine tumors. The physiology of normal and hyperfunctioning endocrine glands is also studied. These research projects are continuing collaborative projects with researchers at Cancer Centrum Karolinska, as well as the endocrine surgery division at the Karolinska University Hospital in Solna and the Yale Endocrine Neoplasia Laboratory at Yale University in Connecticut. From 2013-2014, Dr. Juhlin was a visiting research scholar at Yale School of Medicine.
One of Dr. Juhlin’s most recent publications is Second-Generation Neuroendocrine Immunohistochemical Markers: Reflections from Clinical Implementation,” published in Biology. These markers can help identify the site of primary neuroendocrine tumors as well as helping to ensure a proper diagnosis for NETs and poorly differentiated neuroendocrine carcinoma.
powered by emma
Subscribe to our email list.